The global hemodialysis market reached a value of US$ 80 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Hemodialysis refers to the medical procedure that is performed when the kidney function goes below 10%-15%. In this procedure, a dialyzer, or artificial kidney, is used to filter excess fluids and toxins from the blood and restore the electrolyte balance. It removes waste products such as creatinine and urea from the blood and improves the functioning of the kidneys. It also aids in managing blood pressure levels and balances the concentration of minerals such as sodium, potassium and calcium in the circulatory system. Furthermore, the procedure prevents the accumulation of salts and other toxins that can damage and influence the functioning of other organs in the body.

The growing prevalence of various diseases, such as End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD), across the globe, is one of the key factors driving the growth of the market. These diseases are usually caused by high blood pressure, hypertension, diabetes, excessive alcoholism and drug abuse. There is also a gradual loss of kidney functioning in such cases, which leads to declining health and nerve damage. Hemodialysis assists in stabilizing blood pressure levels and restoring nutritional health. Furthermore, rising consumer awareness regarding the benefits of timely diagnosis and treatment of kidney disorders has increased the adoption of hemodialysis devices. Additionally, various technological innovations, including the introduction of compact-sized machines that can be conveniently used for home-based treatments, are significantly boosting the product demand. Other factors such as enhanced research and development (R&D), favorable government policies to promote public healthcare infrastructure, and the rising trend of automation in treatment processes are projected to drive the market further.

Report Coverage:

Historical, Current and Future Market Trends

Market Breakup by Segment:
Hemodialysis Product
Hemodialysis Service
In-center Services
Home Services

Market Breakup by Modality:
Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis

Market Breakup by End-User:
Independent Dialysis Centres

Market Breakup by Region:
Asia Pacific
North America
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Baxter International, Asahi Kasei Corporation, B. Barun Melsungen, DaVita, Cantel Medical Corporation, Fresenius Medical Care, Nipro Corporation, Rockwell Medical, Medivators, Toray Medical Company Ltd., Nikkiso Co. Ltd., Surni Group, Gambro, Satellite Healthcare Inc., Renacon Pharma Ltd., etc. Key Questions Answered in This Report:

How has the global hemodialysis market performed so far and how will it perform in the coming years?
What are the key regional markets in the global hemodialysis industry?
What has been the impact of COVID-19 on the global hemodialysis industry?
What is the breakup of the market based on the segment?
What is the breakup of the market based on the product?
What is the breakup of the market based on the service?
What is the breakup of the market based on the modality?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global hemodialysis industry?
What are the key driving factors and challenges in the global hemodialysis industry?
What is the structure of the global hemodialysis industry and who are the key players?
What is the degree of competition in the global hemodialysis industry?+